Talis Treatment Information

ACTEMRA

Indication

ACTEMRA® is indicated for the treatment of:

  • Moderate to severe Rheumatoid Arthritis

  • Giant Cell Arteritis

  • Polyarticular Juvenile Idiopathic Arthritis

  • Systemic Juvenile Idiopathic Arthritis

  • Cytokine Release Syndrome

Drug Summary

ACTEMRA (tocilizumab) it works by helping reduce the effects of a substance in the body that can cause inflammation. It can be administered by itself or with methotrexate and other non-biologic medications. It is commonly used to treat rheumatoid arthritis

More Information

For more information, click here to visit the manufacturer's website:  https://www.actemra.com/

 

AVONEX

Indication

AVONEX is indicated for the treatment of

  • Relapsing forms of multiple sclerosis (MS)

  • Clinically isolated syndrome

  • Relapsing-remitting disease

  • Active secondary progressive disease, in adults.

Drug Summary

Avonex is a brand of interferon beta-1a. Interferons are cytokines, which are proteins that cells use to communicate with each other to trigger the protective defenses of the immune system.

More Information

For more information, click here to visit the manufacturer's website:  https://www.avonex.com/

 
 

BENLYSTA

Indication

BENLYSTA® is indicated for the treatment of:

  • Systemic Lupus Erythmatosus

Drug Summary

BENLYSTA (belimumab) is a biologic that reduces certain cells in your immune system, which aid in making lupus active. Adding it to other Lupus medications can maximize treatment outcomes.

More Information

For more information, click here to visit the manufacturer's website:  www.benlysta.com/

BIVIGAM

Indication

BIZIGAM® is indicated for the treatment of:

  • Primary Humoral Immunodeficiency

Drug Summary

BIVIGAM is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP).

More Information

For more information, click here to visit the manufacturer's website:  https://www.bivigam.com/

 
 

Indication

ENTIVIO® is indicated for the treatment of:

  • Ulcerative Colitis

  • Crohn's Disease

Drug Summary

ENTIVIO (vedolizumab) focuses on the GI tract, blocking the movement of white cells located in the gut, which helps control inflammation. It may reduce symptoms, induce and maintain remission, heal the intestinal lining or allow patients to reduce or stop the use of corticosteroids.

More Information

For more information, click here to visit the manufacturer's website:  www.entivio.com/

CARIMUNE

Indication

CARIMUNE® is indicated for the treatment of:

  • Primary immunodeficiencies (PI)

  • Common variable immunodeficiency,

  • X-linked agammaglobulinemia,

  • Severe combined immunodeficiency, 

  • Acute and chronic immune thrombocytopenic purpura (ITP).

Drug Summary

CIMZIA (certolizumab) is a biologic medication that reduces the effects of a substance in the body causing inflammation. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha.

More Information

For more information, click here to visit the manufacturer's website:  www.cimzia.com/

 

Indication

OCREVUS® is indicated for the treatment of:

  • Multiple Sclerosis

Drug Summary

OCREVUS (ocrelizumab) is an immunosuppressive drug used in the treatment of Relapsing and Primary Multiple Sclerosis.

More Information

For more information, click here to visit the manufacturer's website:  www.ocrevus.com/

CIMZIA

Indication

CIMZIA® is indicated for the treatment of:

  • Crohn"s Disease

  • Rheumatoid Arthritis

  • Psoriatic Arthritis

  • Plaque Psoriasis

  • Ankylosing Spondylitis

  • Non-radiographic Axial Spondyloarthrits

  • Adult patients who have not tolerated other medications

Drug Summary

CIMZIA (certolizumab) is a biologic medication that reduces the effects of a substance in the body causing inflammation. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha.

More Information

For more information, click here to visit the manufacturer's website:  www.cimzia.com/

CIMZIA

Indication

CIMZIA® is indicated for the treatment of:

  • Crohn"s Disease

  • Rheumatoid Arthritis

  • Psoriatic Arthritis

  • Plaque Psoriasis

  • Ankylosing Spondylitis

  • Non-radiographic Axial Spondyloarthrits

  • Adult patients who have not tolerated other medications

Drug Summary

CIMZIA (certolizumab) is a biologic medication that reduces the effects of a substance in the body causing inflammation. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha.

More Information

For more information, click here to visit the manufacturer's website:  www.cimzia.com/

 

Indication

CINQAIR® is indicated for the treatment of:

  • Add-on maintenance treatment of patients with severe asthma aged 18 years and older, and with an eosinophilic phenotype.

Drug Summary

Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system. Reslizumab works by reducing levels of a certain type of white blood cell that may contribute to the symptoms of asthma.

More Information

For more information, click here to visit the manufacturer's website:  https://www.cinqair.com/

Indication

PROLIA® is indicated for the treatment of:

  • Osteoporosis

Drug Summary

PROLIA (denosumab) is a human-derived antibody that inactivates the body's bone-breakdown mechanism. It is typically administered twice a year to post-menopausal women with osteoporosis and high-risk fracture, patients with osteoporosis that other treatments have failed and patients who cannot tolerate other osteoporosis treatments.

More Information

For more information, click here to visit the manufacturer's website:  www.prolia.com/

 

Indication

ORENCIA® is indicated for the treatment of:

  • Adult Rheumatoid Arthritis​

  • Polyarticular Juvenile Idiopathic Arthritis (pJIA)

  • Adult Psoriatic Arthritis (PsA)​

Drug Summary

ORENCIA (abatacept) prevents your body's immune system from attacking healthy tissue. It can aid patients who are not achieving relief through their current RA regimens. It is not used as a cure for any autoimmune disorder and will only treat the symptoms of the condition.

More Information

For more information, click here to visit the manufacturer's website:  www.orencia.com/

 

Indication

ELAPRASE® is:

  •  Hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme

Drug Summary

The active substance in Elaprase, idursulfase, is a copy of the human enzyme iduronate-2-sulfatase. It replaces the enzyme that is missing or defective in patients with Hunter syndrome. Supplying the enzyme will help to break down GAGs and stop them building up in body tissue, thereby helping to improve the symptoms of the disease.

 

More Information

For more information, click here to visit the manufacturer's website:  https://www.elaprase.com/

Indication

FERAHEME® is for the treatment of:

  •  Iron Deficiency Anemia in Adults

Drug Summary

Feraheme is in a class of medicines called iron replacement products. It works by replenishing iron so that the body can make more red blood cells that carry oxygen throughout the body.

More Information

For more information, click here to visit the manufacturer's website:  https://www.feraheme.com/

Indication

FERRIECIT® is for the treatment of:

  •  Iron Deficiency Anemia in Adults

Drug Summary

Hemoglobin carries oxygen through your blood to tissues and organs. Myoglobin helps your muscle cells store oxygen. Ferriecit is used to treat iron deficiency anemia (a lack of red blood cells caused by having too little iron in the body) in adults and children at least 6 years old.

More Information

For more information, click here to visit the manufacturer's website:  https://www.sanofi.us/en

 
 

FLEBOGAMMA

Indication

Flebogamma 10% DIF is an immune globulin intravenous (human), indicated for
treatment of:

  • Primary (inherited) Immunodeficiency (PI)

  • Chronic Primary Immune Thrombocytopenia (ITP) in patients 2 years of
    age and older

Drug Summary

Flebogamma DIF works by restoring abnormally low IgG levels to their normal range in the blood. At higher doses, it can help to adjust an abnormal immune system and modulate the immune response.

Flebogamma DIF is made like Flebogamma, another medicine containing human normal immunoglobulin, with some additional steps in the purification of the product from human plasma.

More Information

For more information, click here to visit the manufacturer's website:  https://www.grifols.com/documents/10192/89551/flebo+dif+5+cmi-us-en/f487c733-74c8-4495-9a14-b7ecc8c87e8c

Indication

ENTIVIO® is:

  •  Iron replacement product

Drug Summary

Feraheme is in a class of medicines called iron replacement products. It works by replenishing iron so that the body can make more red blood cells that carry oxygen throughout the body.

More Information

For more information, click here to visit the manufacturer's website:  https://www.feraheme.com/

 

GAMMAGARD

Indication

GAMMAGARD is a treatment:

  • Primary humoral
    immunodeficiency (PI) in adult and pediatric patients two years of
    age or older

  • Multifocal Motor Neuropathy

Drug Summary

GAMMAGARD LIQUID is a ready-to-use liquid medicine that contains immunoglobulin G, or IgG, antibodies, which protect the body against infection. These antibodies, collected from the plasma of healthy people, replace the missing antibodies in primary immunodeficiency (PI) patients.

More Information

For more information, click here to visit the manufacturer's website: https://www.gammagard.com/primary-immunodeficiency/patient

Indication

ENTIVIO® is:

  •  Iron replacement product

Drug Summary

Feraheme is in a class of medicines called iron replacement products. It works by replenishing iron so that the body can make more red blood cells that carry oxygen throughout the body.

More Information

For more information, click here to visit the manufacturer's website:  https://www.feraheme.com/

GAMMAPLEX

Indication

GAMMAGARD is a treatment:

  • Primary humoral immunodeficiency (PI) in adults and pediatric patients two
    years of age and older

  • Chronic immune thrombocytopenic purpura (ITP)

Drug Summary

GAMMPLEX is used to strengthen the body's natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. This medication is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP). 

More Information

For more information, click here to visit the manufacturer's website: https://www.gammaplex.com/prescribing-information/

Indication

ENTIVIO® is:

  •  Iron replacement product

Drug Summary

Feraheme is in a class of medicines called iron replacement products. It works by replenishing iron so that the body can make more red blood cells that carry oxygen throughout the body.

More Information

For more information, click here to visit the manufacturer's website:  https://www.feraheme.com/

GAMMUNEX-C

Indication

GAMMUNEX-C is a treatment:

  • Primary Humoral Immunodeficiency (PI) in patients 2 years of age and older

  • Idiopathic Thrombocytopenic Purpura (ITP)

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Drug Summary

Treatment with GAMUNEX-C provides healthy antibodies to block the immune and inflammatory processes that attack and destroy myelin.

More Information

For more information, click here to visit the manufacturer's website: https://www.gamunex-c.com/en/patient

Indication

ENTIVIO® is:

  •  Iron replacement product

Drug Summary

Feraheme is in a class of medicines called iron replacement products. It works by replenishing iron so that the body can make more red blood cells that carry oxygen throughout the body.

More Information

For more information, click here to visit the manufacturer's website:  https://www.feraheme.com/

 
 
 

SIMPONI ARIA

Indication

SIMPONI ARIA® is indicated for the treatment of:

  • Rheumatoid Arthritis​

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Polyarticular Juvenile Idiopathic arthritis

Drug Summary

SIMPONI ARIA (golimumab) is an immunosuppresive drug used to treat autoimmune diseases by reducing inflammation.

More Information

For more information, click here to visit the manufacturer's website:  www.simponiaria.com/

RITUXAN

Indication

Drug Summary

RITUXAN® is indicated for the treatment of:

  • Rheumatoid Arthritis​

  • Pemphigus Vulgaris

  • GPA/MPA Vasculitis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

RITUXAN (rituximab) is a genetically engineered chimeric/human monoclonal antibody. It is used in combination with other cancer medications to treat Non-Hodgkins Lymphoma by slowing and stopping cell growth. It can also be used to treat rheumatoid arthritis by decreasing joint pain and swelling.

More Information

For more information, click here to visit the manufacturer's website:  www.rituxan.com/

SOLIRIS

Indication

Drug Summary

SOLIRIS® is indicated for the treatment of:

  • Paroxysmal Nocturnal Hemoglobinuria

  • Atypical Hemolytic Uremic Syndrome

  • Generalized Myasthenia Gravis

  • Neuromyelitis Optica Spectrum Disorder

SOLIRIS (eculizumab) is a monoclonal antibody in the immunosuppressive drug category used for the treatment of hemolytic blood disorders. It works by selectively slowing down the complement cascade in the human body

More Information

For more information, click here to visit the manufacturer's website:  www.soliris.com/

SOLU-MEDROL

Indication

SOLU-MEDROL® is indicated for the treatment of:

  • Rheumatoid Arthritis​

  • Pemphigus Vulgaris

  • GPA/MPA Vasculitis

  • Ankylosing Spondylitis

  • Psoriatic Arthritis

  • Plaque Psoriasis

Drug Summary

SOLU-MEDROL (methylprednisolone sodium succinate for injection) is part of a potent class of anti-inflammatory agents known as corticosteroids. It is used for the treatment of inflammation, severe allergies and flares of chronic illnesses.

More Information

For more information, click here to visit the manufacturer's website:  Pfizer

STELARA IV

Indication

STELARA® is indicated for the treatment of:

  • Crohn's Disease

  • Psoriatic Arthritis

  • Plaque Psoriasis

Drug Summary

STELARA (ustekinubab) is an immunosuppressive drug that reduces inflammation due to various autoimmune diseases.

More Information

For more information, click here to visit the manufacturer's website:  www.stelarainfo.com/

 

TYSABRI

Indication

Drug Summary

TYSABRI® is indicated for the treatment of:

  • Multiple Sclerosis

  • Crohn's Disease

TYSABRI (natalizumab) works by impairing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and brain/spinal cord. It is a laboratory-produced antibody and has been proven effective in treating MS symptoms while preventing relapse, vision loss and cognitive decline. It is also used to treat Crohn's Disease.

More Information

For more information, click here to visit the manufacturer's website:  www.tysabri.com

 

VYEPTI

Indication

VYEPTI® is indicated for the treatment of:

  • Migraine in adults​

Drug Summary

VYEPTI (eptinezumab-jjmr) is a powerful preventative treatment for migraine in adults. 

More Information

For more information, click here to visit the manufacturer's website:  www.vyepti.com/

 

XOLAIR

Indication

Drug Summary

XOLAIR® is indicated for the treatment of:

  • Allergic Asthma

  • Chronic Idiopathic Urticaria (UCI)

  • Nasal Polyps

XOLAIR (omalizumab) is an antibody that helps decrease asthma responses in adults and children who are at least 12 years old. It is prescribed for patients not finding relief from an inhaler or corticosteroids. It is also used for conditions causing chronic hives.

More Information

For more information, click here to visit the manufacturer's website:  www.xolair.com/

 

For more information, click here to visit the manufacturer's website:  www.injectafer.com

IRON

Indication

Drug Summary

Iron is indicated for the treatment of:

  • Gastrointestinal Conditions

  • Chronic Kidney Disease

  • Women's Health Conditions

  • Heart Failure

  • Cancer

INJECTAFER® (ferric carboxymaltose injection) is a dextran-free iron replacement product designed to gradually release iron once inside the body, which may decrease the potential for some side effects and give you more iron is less administrations.

VENOFER® (iron sucrose) injection is indicated to treat iron deficiency anemia in adult and pediatric (2 years and older) with chronic kidney disease.

INFeD® (Iron Dextran Injection) is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or have had an unsatisfactory response to oral iron.

More Information